CRAIG HARTIGAN: Open Payments
NPI 1407901127 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,064 in 25 payments from 11 companies in 2025. Trend: 2023 $5,789 · 2024 $1,962 · 2025 $3,064
Food & beverage: $3,064
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 7 | $965 |
| ABBVIE INC. | 5 | $549 |
| Gilead Sciences, Inc. | 2 | $256 |
| Janssen Biotech, Inc. | 2 | $249 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $233 |
| Ardelyx, Inc. | 2 | $233 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| GENZYME CORPORATION | 1 | $120 |
| Ipsen Biopharmaceuticals, Inc | 1 | $105 |
Products named: REZDIFFRA, MAVYRET, Livdelzi, TREMFYA, ENTYVIO, IBSRELA, SKYRIZI, ZENPEP.
Industry payments across PA — which companies pay providers there.
